Corbus Pharmaceuticals Holdings, Inc.
CRBP
$6.68
$0.558.97%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 132.79M | 149.06M | 159.36M | 147.03M | 120.10M |
| Total Receivables | 1.10M | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 3.19M | 3.63M | 1.24M | 1.00M | 1.31M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 285.00K | 285.00K | 285.00K | 285.00K | 285.00K |
| Total Current Assets | 137.36M | 152.98M | 160.89M | 148.31M | 121.70M |
|
|
|||||
| Total Current Assets | 137.36M | 152.98M | 160.89M | 148.31M | 121.70M |
| Net Property, Plant & Equipment | 2.19M | 2.52M | 2.90M | 3.28M | 3.66M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 385.00K | 385.00K | 385.00K | 385.00K | 385.00K |
| Total Assets | 139.93M | 155.88M | 164.17M | 151.98M | 125.74M |
|
|
|||||
| Total Accounts Payable | 4.07M | 4.79M | 2.89M | 1.15M | 2.08M |
| Total Accrued Expenses | 5.90M | 5.43M | 7.18M | 10.49M | 9.40M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 1.65M | 1.61M | 1.56M | 12.34M | 14.43M |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | 10.90K |
| Total Other Current Liabilities | -- | -- | -- | -- | 10.90K |
| Total Current Liabilities | 11.62M | 11.82M | 11.63M | 23.98M | 25.92M |
|
|
|||||
| Total Current Liabilities | 11.62M | 11.82M | 11.63M | 23.98M | 25.92M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 1.21M | 1.63M | 2.05M | 2.46M | 2.86M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 12.83M | 13.45M | 13.67M | 26.44M | 28.78M |
|
|
|||||
| Common Stock & APIC | 621.00M | 619.29M | 617.65M | 579.51M | 540.88M |
| Retained Earnings | -493.87M | -476.89M | -467.36M | -453.58M | -443.58M |
| Treasury Stock & Other | -23.00K | 35.00K | 207.00K | -388.00K | -328.50K |
| Total Common Equity | 127.11M | 142.43M | 150.50M | 125.54M | 96.97M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 127.11M | 142.43M | 150.50M | 125.54M | 96.97M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 127.11M | 142.43M | 150.50M | 125.54M | 96.97M |
|
|
|||||